OnKure Therapeutics (OKUR) Return on Sales [ROS] (2024 - 2026)
Powered by 
Analysis
OnKure Therapeutics (OKUR) Return on Sales [ROS] (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,124.59 Bn | 1,093.18 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 634.91 Bn | 554.77 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 505.42 Bn | 478.53 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 357.53 Bn | 311.91 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 289.90 Bn | 253.89 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 264.89 Bn | 238.58 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.79 Bn | 193.19 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.74 Bn | 168.94 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.08 Bn | 117.73 Bn | 10.94 Bn | 28.37% |
| 10 | OnKure Therapeutics | 126.67 Mn | -371.26 Mn | - | -1,088.15% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,088.15% |
| Mar 31, 2026 | -3,409.39% |
| Dec 31, 2025 | -2,270.90% |
| Sep 30, 2025 | -1,932.79% |
| Jun 30, 2025 | -1,747.75% |
| Mar 31, 2025 | -1,581.40% |
| Dec 31, 2024 | -1,554.36% |
| Jun 30, 2024 | -7,030.88% |
API Access
OnKure Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=OKUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "OKUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=OKUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();